GlobeNewswire PharmaOriginal article
OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme
PartnershipAAV Gene Therapy ProgrammePositive
AI Analysis
Summary
OXB has signed an agreement with Plowshare Therapies to provide process development and GMP manufacturing services for AAV gene therapies targeting rare genetic diseases, with potential for expansion to additional programs and later-stage manufacturing.
Importance:5/10
Sentiment:
0.60
CDMOGene TherapyAAVManufacturingPartnershipRare Genetic Diseases
Related Companies
Read the original article
Published by GlobeNewswire Pharma on July 16, 2026 11:00 AM
